Picard Medical, Inc. (PMI)

Picard Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-31.55	-21.06	-15.57	-11.17
Depreciation & Amortization	0.17	0.23	0.59	0.55
Stock-Based Compensation	0.75	0.89	0.13	0.15
Other Adjustments	17.12	7.11	0.94	1.68
Change in Receivables	-0.38	0.12	0.25	0.21
Changes in Inventories	1.19	-1.33	-0.45	-1.59
Changes in Accounts Payable	-1.98	2.21	1.61	0.11
Changes in Accrued Expenses	0.47	0.35	1.75	-0.26
Changes in Other Operating Activities	-0.24	-0.38	0.12	-0.39
Operating Cash Flow	-14.45	-11.87	-10.63	-10.72
Capital Expenditures	-	-	-0.01	-0.03
Other Investing Activities	-	-	-0	-0.01
Investing Cash Flow	-	-	-0.01	-0.04
Long-Term Debt Issued	8.83	13.12	9.08	5.55
Long-Term Debt Repaid	-8.41	-1.38	-0.89	-0.03
Net Long-Term Debt Issued (Repaid)	0.42	11.74	8.19	5.52
Issuance of Common Stock	15.21	-	-	-
Net Common Stock Issued (Repurchased)	15.21	-	-	-
Issuance of Preferred Stock	-	-	2.65	-
Net Preferred Stock Issued (Repurchased)	-	-	2.65	-
Financing Cash Flow	17.29	11.74	10.84	5.52
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.04	-0.02	-0.11	0.13
Net Cash Flow	2.81	-0.15	0.09	-5.1
Free Cash Flow	-14.45	-11.87	-10.64	-10.75
FCF Margin	-302.64%	-270.42%	-211.01%	-261.42%
Free Cash Flow Per Share	-0.73	-1.49	-1.34	-1.92
Levered Free Cash Flow	-33.81	-10.92	-6.21	-8.77
Unlevered Free Cash Flow	-14.23	-12.63	-11.9	-12.7

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q